BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8647157)

  • 1. The additional predictive value contributed by quantitative chromatin pattern description as compared to DNA ploidy level measurement in 257 superficial bladder transitional cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Raviv G; Janssen T; Roels H; Pasteels JL; Schulman C; Kiss R
    Eur Urol; 1996; 29(2):245-51. PubMed ID: 8647157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of digital image analysis of chromatin texture in Feulgen-stained nuclei to predict recurrence of low grade superficial transitional cell carcinoma of the bladder.
    van Velthoven R; Petein M; Oosterlinck WJ; Roels H; Pasteels JL; Schulman C; Kiss R
    Cancer; 1995 Jan; 75(2):560-8. PubMed ID: 7529131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted chromatin texture characterization of Feulgen-stained nuclei in a series of 331 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Zlotta A; Oosterlinck WJ; van der Meijden A; Zandona C; Roels H; Pasteels JL; Schulman C; Kiss R
    J Pathol; 1994 Jul; 173(3):235-42. PubMed ID: 7523643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bladder transitional cell carcinoma rating, systematization of grading and value of DNA ploidy].
    Hierro Martín I; Alvarez Pérez M; Blanes Berenguel A; Quiñonero Díaz A; Díaz Cano S; García González I; Matilla Vicente A
    Actas Urol Esp; 1999 Jun; 23(6):489-96. PubMed ID: 10464957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of Markovian nuclear texture to predict progression in surface transitional cell carcinoma of the bladder].
    Alvarez Pérez M; Blanes Berenguel A; García González I; Hierro Martín I; Vicioso Recio L; Matilla Vicente A
    Actas Urol Esp; 1999 Jun; 23(6):497-504. PubMed ID: 10464958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
    Dekairelle AF; Tombal B; Cosyns JP; Gala JL
    Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The computer-assisted microscope analysis of Feulgen-stained nuclei linked to a supervised learning algorithm as an aid to prognosis assessment in invasive transitional bladder cell carcinomas.
    Decaestecker C; Petein M; van Velthoven R; Janssen T; Raviv G; Pasteels JL; Schulman C; Van Ham P; Kiss R
    Anal Cell Pathol; 1996 May; 10(3):263-80. PubMed ID: 8798287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
    Nenning H; Rassler J; Minh DH; Stolzenburg JU
    Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinomas of the bladder.
    Decaestecker C; van Velthoven R; Petein M; Janssen T; Salmon I; Pasteels JL; van Ham P; Schulman C; Kiss R
    J Pathol; 1996 Mar; 178(3):274-83. PubMed ID: 8778332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.